• Skip To Content
  • Skip To Navigation
  • Skip To Search

University of Notre Dame

Advancing Evidence for the Global Implementation of Spatial Repellents

  • About
  • Our Team
  • Spatial Repellents
  • Our Approach
  • News & Events
  • Home
  • Menu
  1. Home ›
  2. News & Events ›
  3. News

News

Subscribe to News

  1. Mc 4

    New frontiers in vector control

    April 11, 2022

  2. Img 20210623 Wa0007

    Second spatial repellent trial for Unitaid-funded research program begins in Mali

    August 11, 2021

  3. Fang Liu

    Liu named Fellow of American Statistical Association

    May 06, 2021

  4. 20190320 100033 Revised3

    World Malaria Day 2021

    April 23, 2021

  5. University leads public health research effort to prevent vector-borne diseases

    April 19, 2021

  6. 4285 Jhu Kenya

    Beyond Bed Nets: Study Shows Consumers in Kenya Shopping for Alternative Mosquito Products

    April 05, 2021

  7. 3

    Notre Dame and partners begin first spatial repellent trials for Unitaid-funded research program

    March 25, 2021

  8. Iquitos River

    Podcast: On Mosquito-Borne Diseases and Spatial Repellents—Nicole Achee, Notre Dame

    January 28, 2021

  9. Spatial Repellent Feature

    Study provides insight into spatial repellents as method to reduce infection of vector-borne diseases, encourages additional research

    November 11, 2019

  10. Mc 4

    Notre Dame receives its largest research award to study spatial repellents against mosquito-borne diseases

    November 11, 2019

View Archive
  • Home
  • About
  • Our Team
  • Spatial Repellents
  • Our Approach
  • News & Events
    • News
    • Events
  • News
  • Events
Unitaid - Innovation in Global Health

This project is made possible thanks to Unitaid funding and support. Unitaid is a global health agency engaged in finding innovative solutions to prevent, diagnose, and treat diseases more quickly, effectively, and for affordable prices, in low- and middle-income countries. Unitaid’s work includes funding initiatives to address major diseases such as HIV/AIDS, malaria, and tuberculosis, as well as HIV co-infections and co-morbidities such as cervical cancer and hepatitis C, and cross-cutting areas, such as fever management. Unitaid is now applying its expertise to address challenges in advancing new therapies and diagnostics for the COVID-19 pandemic, serving as a key member of the Access to COVID Tools Accelerator. Unitaid is hosted by the World Health Organization.

Advancing Evidence for the Global Implementation of Spatial Repellents

Notre Dame, IN 46556 USA aegis@nd.edu

  • Twitter

© 2023 University of Notre Dame

University of Notre Dame
  • Search
  • Mobile App
  • News
  • Events
  • Visit
  • Accessibility
  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • LinkedIn